Legal & General Group
ENTL

Legal & General Group’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Legal & General Group’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,980
Closed -$48K – 3306
2017
Q4 		$48K Hold
1,980
– – ﹤0.01% 2887
2017
Q3 		$37K Hold
1,980
– – ﹤0.01% 3011
2017
Q2 		$33K Buy
1,980
+769
+64% +$10.7K ﹤0.01% 3018
2017
Q1 		$17K Sell
1,211
-105
-8% -$1.69K ﹤0.01% 3122
2016
Q4 		$25K Buy
+1,316
New +$25.2K ﹤0.01% 3084

Legal & General Group's ENTL Position: Q1 2018 in Review

Legal & General Group sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 1,980 shares — an estimated $48K sold.

Legal & General Group first reported a position in ENTL in Q4 2016 and held it in 5 quarters. The position peaked at $48K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Legal & General Group reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Legal & General Group sold 1,980 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $48K.
  • Legal & General Group first reported a position in Entellus Medical, Inc. Common Stock in Q4 2016 and held it in 5 quarters.
  • Legal & General Group's Entellus Medical, Inc. Common Stock position peaked at $48K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Legal & General Group's 13F filing for Q1 2018, filed 17 May 2018.